Results 171 to 180 of about 2,350,568 (218)
Some of the next articles are maybe not open access.

Photoprotection of the eye in PUVA therapy

British Journal of Dermatology, 1978
Photochemotherapy with psoralens, now widely used in the therapy of psoriasis, vitiligo and mycosis fungoides, has been proposed to have the capacity, during long-term therapy, to induce ocular damage, e.g. cataract. This view is based on animal experiments (Cloud, Hakim & Griffin, 1960, 1961; Free-man & Troll, 1969) and as a consequence adequate ...
openaire   +2 more sources

PUVA-Bad-Therapie

Der Hautarzt, 1994
Systemic PUVA photochemotherapy is widely used for a variety of skin diseases. Administration of 8-methoxypsoralen in a dilute bathwater solution may be an effective alternative therapy with no systemic side-effects and requiring smaller amounts of UVA to induce the required phototoxic response.
Martina Kerscher   +2 more
openaire   +1 more source

PUVA therapy.

American family physician, 1991
PUVA is an acronym for psoralen plus ultraviolet-A radiation. This form of photochemical therapy is commonly used in the treatment of psoriasis and vitiligo, but it is also beneficial in other dermatologic diseases. An understanding of psoralen's mechanism of action and the unique properties of the various psoralen preparations is important in ensuring
T N, Helm   +3 more
openaire   +1 more source

PUVA therapy of chronic actinic dermatitis

British Journal of Dermatology, 1985
Four men with long-standing chronic actinic dermatitis were treated with a modified PUVA regime which initially included generalized applications of topical steroids given immediately after PUVA exposure. All patients are now free of rash, no longer need protection from UV radiation, and are being maintained on twice monthly PUVA therapy (IO J/cm2).
C, Hindson, J, Spiro, A, Downey
openaire   +2 more sources

Melanocyte changes following PUVA therapy

Journal of the American Academy of Dermatology, 1979
The effect of psoralens and long-wave ultraviolet light (PUVA) therapy on human melanocytes was studied at the ultrastructural level. The results demonstrate an increase in the number of melanocytes, a change in their location, and an increase in the size of the melanosomes.
A S, Zelickson, J H, Mottaz, S A, Muller
openaire   +2 more sources

PUVA therapy of diffuse granuloma annulare

Clinical and Experimental Dermatology, 1988
3 cas de granulome annulaire diffus interessant 20 a 40% de la surface corporelle et de duree variable ont ete traites par la PUVAtherapie.
T C, Hindson, J G, Spiro, H, Cochrane
openaire   +2 more sources

Livedoid vasculitis responding to PUVA therapy

International Journal of Dermatology, 2001
AbstractBackground  Livedoid vasculitis is a chronic disorder manifested as recurrent, painful, reticulated, and ulcerative lesions of the legs, which result in ivory atrophic scars with peripheral telangiectasia and hyperpigmentation. Its etiology remains obscure and therapy is difficult.
J H, Lee   +4 more
openaire   +2 more sources

PUVA, Etretinate, and PUVA-Etretinate Therapy for Pustulosis Palmoplantaris

Archives of Dermatology, 1987
Thirty patients with severe pustulosis palmoplantaris completed a placebo-controlled comparative trial. Patients were randomly allocated to placebo or etretinate therapy; after two weeks, psoralen plus long-wave ultraviolet light (PUVA) treatment was instituted on one hand or foot, while the other hand or foot served as an untreated control.
K, Rosén, H, Mobacken, G, Swanbeck
openaire   +2 more sources

Phototherapy and Puva Therapy

1988
By common usage phototherapy has come to mean the treatment of disease by ultraviolet (UV) or visible radiation either alone or with an added chemical. In dermatology phototherapy is generally restricted to describe treatment of skin disease with UV-B (290–320 nm) and the added chemicals are topically applied coal tar or anthralin.
openaire   +1 more source

Autografting and PUVA A Combination Therapy for Vitiligo

The Journal of Dermatologic Surgery and Oncology, 1992
A novel approach to the management of vitiligo is described using a combination of epidermal autografts transplanted into the depigmented areas and psoralen‐ultraviolet‐A (PUVA) therapy. Epidermal autografts can be obtained rapidly and in large numbers using a device that combines the synergistic effects of suction and heat on the skin.
J W, Skouge   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy